What is the ROCE (Return on Capital Employed) of Biomerieux this year?
The ROCE of Biomerieux is 0.12 undefined this year.
Biomerieux ROCE 2025
Biomerieux ROCE
0.12
Ticker
BIM.PA
ISIN
FR0013280286
WKN
A2DXZH
In 2025, Biomerieux's return on capital employed (ROCE) was 0.12, a -28.19% increase from the 0.16 ROCE in the previous year.
Biomerieux Aktienanalyse
What does Biomerieux do?
Biomerieux SA is a French company that operates in the field of in vitro diagnostics. The company was founded in 1963 by French biologist Alain Merieux and has since continued to grow. Today, Biomerieux employs around 12,000 people in over 150 countries worldwide and is listed on the Paris Stock Exchange. Biomerieux's business model is based on the development, production, and marketing of diagnostic products for various areas of medicine. This includes infectious diseases, cancer, and cardiovascular diseases. The company is divided into two main business segments: Clinical Diagnostics and Industrial Microbiology. Under the Clinical Diagnostics segment, Biomerieux offers a wide range of diagnostic products for infectious diseases, including molecular diagnostics, blood-based tests, and laboratory automation solutions. Some of the most well-known products include the VIDAS immunodiagnostic test, the FilmArray multiplex PCR test, and the VITEK automated system for microorganism identification. Under the Industrial Microbiology segment, Biomerieux is a leading provider of products for the microbiological analysis of food, beverages, and pharmaceutical products. The company offers a wide range of products for microbiological quality control, which help ensure the safety and quality of food and pharmaceutical products. These include the TEMPO system for assessing microorganism growth and the Bactalert blood culture system for rapid detection of bacteria in blood cultures. In addition to its main business segments, Biomerieux also offers specialty products for use in veterinary diagnostics and water analysis. The company works closely with clinical laboratories and health authorities to improve the diagnosis of infectious diseases and combat epidemics. Over the years, Biomerieux has built a strong research and development department focused on developing innovative diagnostic products. The company has also made a number of strategic acquisitions to expand its product portfolio and enter new markets. For example, in 2020, Biomerieux acquired Suzhou Hybiome Biomedical Engineering in China to strengthen its presence in the Chinese market. In summary, Biomerieux is a leading company in the field of in vitro diagnostics. Its wide range of products and global network make it an important partner for laboratories, hospitals, and the food and pharmaceutical industries. With its strong research and development department and strategic acquisitions, Biomerieux will continue to play a crucial role in the fight against infectious diseases and the improvement of patient care. Biomerieux ist eines der beliebtesten Unternehmen auf Eulerpool.com.ROCE Details
Unraveling Biomerieux's Return on Capital Employed (ROCE)
Biomerieux's Return on Capital Employed (ROCE) is a financial metric that measures the company's profitability and efficiency with respect to the capital employed. It is calculated by dividing earnings before interest and tax (EBIT) by the employed capital. A higher ROCE indicates that the company is effectively utilizing its capital to generate profits.
Year-to-Year Comparison
Analyzing Biomerieux's ROCE annually provides valuable insights into its efficiency in using its capital to generate profits. An increasing ROCE indicates improved profitability and operational efficiency, whereas a decrease might signal potential issues in capital utilization or business operations.
Impact on Investments
Biomerieux's ROCE is a critical factor for investors and analysts for evaluating the company’s efficiency and profitability. A higher ROCE can make the company an attractive investment, as it often signifies that the firm is generating adequate profits from its employed capital.
Interpreting ROCE Fluctuations
Changes in Biomerieux’s ROCE are attributed to variations in EBIT or the capital employed. These fluctuations offer insights into the company’s operational efficiency, financial performance, and strategic financial management, assisting investors in making informed investment decisions.
Frequently Asked Questions about Biomerieux stock
How has the ROCE (Return on Capital Employed) of Biomerieux developed compared to the previous year?
The ROCE of Biomerieux has increased by -28.19% decreased compared to the previous year.
What does a high ROCE (Return on Capital Employed) mean for investors of Biomerieux?
A high Return on Capital Employed (ROCE) indicates that Biomerieux has efficient capital utilization and is able to achieve a higher return on its invested capital. This can be appealing to investors.
What does a low ROCE (Return on Capital Employed) mean for investors of Biomerieux?
A low ROCE (Return on Capital Employed) can indicate that Biomerieux has an inefficient utilization of its capital and may have difficulty in achieving a satisfactory return on its invested capital. This can be uncertain or unattractive for investors.
How does an increase in ROCE from Biomerieux impact the company?
An increase in the ROCE of Biomerieux can be an indicator of improved company efficiency and show that it is achieving higher profits in relation to its investments.
How does a reduction in the ROCE of Biomerieux affect the company?
A decrease in ROCE of Biomerieux can be an indicator of deteriorated efficiency of the company, indicating that it is generating lower profits in relation to its investments.
What are some factors that can influence the ROCE of Biomerieux?
Some factors that can affect Biomerieux's ROCE include efficiency in managing assets, profitability of investments, cost efficiency, and market conditions.
Why is the ROCE of Biomerieux so important for investors?
The ROCE of Biomerieux is important for investors as it is an indicator of the company's efficiency and shows how successful the company is in relation to its investments. A high ROCE can indicate strong financial performance of the company.
What strategic measures can Biomerieux take to improve the ROCE?
To improve the ROCE, Biomerieux can take measures such as increasing efficiency in asset management, optimizing investments, cost savings, and exploring new revenue sources. It is important for the company to conduct a thorough review of its operations to determine the best strategic actions to improve the ROCE.
How much dividend does Biomerieux pay?
Over the past 12 months, Biomerieux paid a dividend of 0.85 EUR . This corresponds to a dividend yield of about 0.79 %. For the coming 12 months, Biomerieux is expected to pay a dividend of 0.94 EUR.
What is the dividend yield of Biomerieux?
The current dividend yield of Biomerieux is 0.79 %.
When does Biomerieux pay dividends?
Biomerieux pays a quarterly dividend. This is distributed in the months of July, July, July, July.
How secure is the dividend of Biomerieux?
Biomerieux paid dividends every year for the past 24 years.
What is the dividend of Biomerieux?
For the upcoming 12 months, dividends amounting to 0.94 EUR are expected. This corresponds to a dividend yield of 0.87 %.
In which sector is Biomerieux located?
Biomerieux is assigned to the 'Health' sector.
Wann musste ich die Aktien von Biomerieux kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Biomerieux from 6/11/2024 amounting to 0.85 EUR, you needed to have the stock in your portfolio before the ex-date on 6/7/2024.
When did Biomerieux pay the last dividend?
The last dividend was paid out on 6/11/2024.
What was the dividend of Biomerieux in the year 2024?
In the year 2024, Biomerieux distributed 0.85 EUR as dividends.
In which currency does Biomerieux pay out the dividend?
The dividends of Biomerieux are distributed in EUR.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
The Biomerieux stock can be added to a savings plan with the following providers: Trade Republic
Andere Kennzahlen von Biomerieux
Our stock analysis for Biomerieux Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Biomerieux Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
